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We studied the eﬀect of food restriction, overfeeding, and normofeeding on cachexia, inﬂammatory and metabolic parameters,
and insulin sensitivity in chronic adjuvant arthritis (AA) in rats. Food restriction during AA increased circulating ghrelin,
corticosterone, decreased leptin, and ameliorated arthrogram score and systemic inﬂammation compared to normofeeding.
Overfeeding worsened arthrogram score and systemic inﬂammation, and led to lipid accumulation in the liver, but not to
alterations of adipokine and ghrelin plasma levels relative to normofeeding. Independently of feeding status, AA induced cachexia,
in which modulation of mRNA expressions for appetite-regulating neuropeptides (NPY, AgRP, POMC, CART) in the arcuate
nucleus (ARC) does not play a primary role. The overexpression of IL-1β mRNA in the ARC suggests its role in the mechanisms
of impaired energy balance during AA under all feeding conditions. Normal HOMA index in all arthritic groups does not indicate
the development of insulin resistance by feeding interventions in these rats.
1.Introduction
The world wide growing incidence of obesity has triggered
increased research into the adverse health consequences of
this condition. Particular attention has been paid to white
adipose tissue- (WAT-) derived adipokines. At present, there
is a large body of evidence that chronic subclinical inﬂam-
mation associated with changes in endocrine functions of
adipose tissue leads to metabolic disturbances including
developmentofinsulinresistance,diabetes,andcardiovascu-
lar disease [1]. However, an important question still remains.
Whether increased levels of systemic inﬂammation during
obesity can also predispose susceptible individuals to the
development of autoimmune inﬂammatory diseases such as
rheumatoid arthritis (RA).
The relationship between obesity and RA is diﬃcult to
settle as chronic RA brings about cachexia, and there is
little documentation on body composition before the onset
of the disease. The literature describing the link between
obesity and RA failed to show diﬀerences in prevalence of
RA between obese and nonobese patients [2]. It has to
be noted that severe rheumatoid disease is associated with
inﬂammatory cachexia characterized by the loss of lean body
tissue that is often compensated for by gain in body fat. Thus
about 85% of RA patients have a normal body mass index
(BMI) [3]. Recently, it has been described that higher BMI
was associated with increased leptin levels and a less severe
radiographic joint damage of small joints in patients with
RA [4, 5]. In contrast, leptin has been shown to positively
correlate with the disease activity score in 28 joints (DAS28),2 Mediators of Inﬂammation
and the IL-6, and CRP levels [5]. Interestingly, reduction
of leptin levels in patients with RA due to starving was
accompanied by decreased CD4+ lymphocyte activation and
increased IL-4 production, which resulted in attenuation
of disease activity [6]. Under experimental conditions, in
rodent models of RA, chronic arthritis was less severe in food
restricted rats [7], or in ob/ob mice with leptin deﬁciency [8].
Leptin is an adipokine with proinﬂammatory nature that
can promote immune system reactivity and autoimmunity
[9–11]. It positively correlates with BMI and suppresses
appetite through regulation of speciﬁc hypothalamic neu-
ropeptides: pro-opiomelanocortin (POMC), cocaine- and
amphetamine-regulated transcript (CART), neuropeptide Y
(NPY), and agouti-related peptide (AgRP) [12]. Oppositely
to leptin, gastric hormone ghrelin negatively correlates with
BMI, stimulates appetite at the hypothalamic level [13],
and inhibits leptin-induced expression of pro-inﬂammatory
cytokines [14]. Another adipokine, adiponectin, acts as a
protective factor in some inﬂammation connected patholo-
gies such as atherosclerosis, cardiovascular disease, insulin
resistance, and type 2 diabetes mellitus. Both proinﬂam-
matory and antiinﬂammatory eﬀects of adiponectin have
been reported with regard to joint inﬂammation [10].
Visfatin is an adipokine known for its insulin-mimicking/-
sensitizing eﬀects, pro-inﬂammatory properties, as well as
for its activation by inﬂammation [15].
Becausenumerousstudieshaveindicatedthatadipokines
can play a role in joint degenerative diseases including
inﬂammatory arthritis [16], it can be hypothesized that
obesity-induced changes in adipokine levels towards inﬂam-
matory phenotype may worsen the outcome of arthri-
tis. Conversely, fasting associated with body fat loss, and
increased ghrelin levels may lead to antiinﬂammatory phe-
notype, and to milder symptoms of arthritis. Therefore,
in this study we investigated the eﬀect of feeding sta-
tus (overfeeding, normofeeding, and food restriction) on
chronic arthritis severity, arthritis-associated cachexia, and
metabolic responses. For overfeeding we have used a model
of early-life overnutrition induced by reduced litter size
and followed by high-fat diet consumption. This model
produces accumulation of fat mass, hyperleptinemia, and
hypoadiponectinemia by the age of 8 weeks [17]. The
model of 40% food restriction was used on the basis of
our previous work, where we observed the improvement of
arthritis, but adipokines were not examined in that study
[7]. In this study we are describing interventions of leptin,
ghrelin,adiponectin,andvisfatinwithinﬂammation,hepatic
lipid accumulation, insulin sensitivity, and hypothalamic
orexigenic and anorexigenic peptide expressions in high-fat
diet fed, food restricted, and normally fed arthritic rats.
2.MaterialsandMethods
2.1. Animals and Experimental Design. Male 21-days old
Lewis rats, after birth adjusted to litter sizes of 4 (small
litter = SL) or 8 (normal litter = NL) pups with their
nursing females were obtained from Charles River (Ger-
many). The litters were kept under 12-h light/dark cycle
(light on from 6:00 a.m. to 6:00 p.m.) with controlled
humidity and temperature on standard pellet diet in an
animal room of the Department of Normal, Pathological
and Clinical Physiology, Third Faculty of Medicine, Charles
University in Prague. On day 23 of life the pups were
separated from their nursing females, and were housed 4
per cage. The NL pups were given a standard rodent diet
containing 10% calories as fat (ST1, Velaz, Czech Republic),
and the SL pups were given a high-fat diet (D12451;
Ssniﬀ, Germany) containing 45% calories as fat [39.5% lard
(containing 39% saturated fat, 56% unsaturated fat, and
0.95% cholesterol) and 5.5% soybean oil (containing 16%
saturated fat and 81% unsaturated fat)]. Both groups had
free access to water and respective diets.
At the age of 8 weeks the rats were divided into following
6 groups according to dietary regime and AA induction:
normally fed controls from NL (CN; n = 8); normally fed
arthritic rats from NL (AA-N; n = 8); high-fat diet fed
controls from SL (SHF; n = 8); high-fat diet fed arthritic
rats from SL (AA-SHF; n = 8); food-restricted controls
from NL (FR; n = 8); food-restricted arthritic rats from
NL (AA-FR; n = 8). FR groups were given 60% of the
standard diet consumed by their normally fed counterparts
on the previous day. Diets were given regularly between 8
a.m. and 9 a.m., and food consumption per cage and body
mass were measured daily at the same time of day. AA was
induced to rats by a single subcutaneous injection of 100μL
of complete Freund’s adjuvant (cFA) 2cm from the base of
the tail as described previously in [18]. These rats had cage
feeder assembled for easy food access.
The rats were decapitated on day 18 of AA after
a 12h fast. Trunk blood was collected into tubes with
EDTA, centrifuged and plasma was stored at −−70
◦C.
Mesenteric and epididymal adipose tissues were dissected
and weighed. Liver and brain was dissected, snapfrozen in
liquid nitrogen, and stored at −−70
◦C until analyzed.
All the organs were collected in a native form without
perfusionbecauseinintegratedorganismthecontributionof
factor/cell present in the blood or in the individual organ is
not distinguishable. The animals were treated in accordance
with the national law of the Czech Republic on the use
of laboratory animals no. 246/1992 (fully compatible with
EuropeanCommunityCouncildirectives86/609/EEC)based
on the project approved by the Committee for Protection
of Experimental Animals at the Third Faculty of Medicine,
Prague.
2.2. Arthrogram Score. Paw swelling was measured volu-
metrically on days 12, 15, and 18 after AA induction.
The periarticular erythema and swelling of each paw was
evaluated by scoring from 1 to 5. The severity of arthritis
was quantiﬁed by the sum of the scores for the paws, with
the maximum possible scores of 20 per rat (Svik, personal
communication).
2.3. Hypothalamic Arcuate Nucleus Isolation. The hypotha-
lamic arcuate nucleus (ARC) was isolated from the frozen
brains by a punching technique [19].Mediators of Inﬂammation 3
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Figure 1: Body mass (a) and food intake (b) in control rats on standard diet (CN=  ), high-fat diet (SHF=  ), and food restriction
(FR=  ), and in arthritic rats on standard diet (AA-N= ), high-fat diet (AA-SHF=  ), and food restriction (AA-FR= ♦) in selected days
after cFA inoculation. Values for food intake are presented as means of 2 cages (4 rats per cage). Statistical signiﬁcance between the body
mass values in arthritic rats and their corresponding controls on the same dietary regime: ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001. Signiﬁcant
diﬀerence between AA-N and AA-SHF: †P<. 05. First day of signiﬁcant diﬀerences: CN versus SHF ×P<. 05, FR versus CN aP<. 05, FR
versus SHF bP<. 001, AA-FR versus AA-N ###P<. 001, and AA-FR versus AA-SHF +++P<. 001. Eﬀects of dietary interventions on the
severity of arthritis expressed by arthrogram score (c). Signiﬁcant diﬀerence between AA-FR and AA-N: ∗P<. 05, ∗∗∗P<. 001; signiﬁcant
diﬀerence between AA-FR and AA-SHF: +++P<. 001; signiﬁcant diﬀerence between AA-SHF and AA-N: †P<. 05.
Table 1: Arthrogram score evaluation according to the degree of
arthritic involvement for each paw.
Score Degree of arthritic involvement
0N o n e
1 Erythema without swelling
2 Erythema + minor swelling (paw volume 1.5–1.7ml)
3 Erythema + moderate swelling (paw volume 1.8–2.3ml)
4 Erythema + severe swelling (paw volume 2.4–2.6ml)
5 Erythema + the severest swelling (paw volume >2.6ml)
2.4. Plasma Determinations and Homa Index. All parameters
were measured after a 12h fast. Levels of plasma leptin,
adiponectin, visfatin, insulin, and total ghrelin were deter-
mined by speciﬁc rat RIA kits from Linco Research (St.
Charles,MO).Corticosteroneplasmalevelsweredetermined
by the rat and mouse corticosterone high sensitivity EIA
kit (IDS, Boldon, UK). Plasma CRP levels were measured
by the commercial rat ELISA kit from ICL (Newberg, OR).
The basal level of glucose in plasma was measured by
the autoanalyser Hitachi 911 (Hitachi, Japan). Homeostasis
model assessment (HOMA) index was calculated using the
following formula: fasting plasma insulin (μU/mL) × fasting
plasma glucose (mmol/L)/22.5.
2.5. Triglyceride and Cholesterol Determinations in the Liver.
Triglyceride concentrations in the liver were determined by
the modiﬁed method of Jover [20]. Liver tissue (100mg)
was homogenized and extracted in chloroform/methanol
(2:1). The interfering phospholipids were removed by
absorption from the liver extract on silica gel. Puriﬁed
extracts were evaporated and triglycerides hydrolyzed with
potassium hydroxide. Released fatty acids were removed
by extraction into heptane. Finally, the released glycerol
was oxidized by periodic acid, and after the reaction with
phenylhydrazine, a colored complex was measured spec-
trophotometrically at 530nm. Cholesterol was determined
by the modiﬁed method of Abel et al. [21]. Liver tissue
(100mg) was homogenized in chloroform/methanol (1:1).
After lipid extraction, the Lieberman-Burchard colorimetric
assay was used for the detection of cholesterol. Cholesterol
concentrations were determined spectrophotometrically at
650nm.4 Mediators of Inﬂammation
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Figure 2: Plasma corticosterone (a), plasma CRP (b), IL-1β mRNA expression (c), and CRP mRNA expression (d) in the liver of healthy
control (CN, SHF, FR) and arthritic rats (AA-N, AA-SHF, AA-FR) measured on day 18 after cFA inoculation. Results of mRNA expressions
are expressed in arbitrary units as the ratio of given mRNA to GAPDH. Signiﬁcant diﬀerences between healthy controls on diﬀerent dietary
regime: ×P<. 05, ×××P<. 001. Statistical signiﬁcances: control rats versus arthritic rats on the same dietary regime ∗P<. 05, ∗∗P<. 01,
∗∗∗P<. 001; AA-FR versus AA-N #P<. 05, ###P<. 001; AA-FR versus AA-SHF ++P<. 01; AA-SHF versus AA-N ††P<. 01. For abbreviations
see Figure 1.
2.6. RNA Preparation and Quantitative TaqMan PCR Pro-
cedure in the Liver. Liver tissue was homogenized using
QIAshredder (Qiagen, Valencia, CA). Total RNA was iso-
lated using RNeasy Mini Kit (Qiagen, Valencia, CA). The
RNA samples were reversely transcribed to cDNA using
SuperScript III RT enzyme (Invitrogen, Carlsbad, CA). The
quantitative PCR reaction was performed using TaqMan
Assays (Applied Biosystems, Foster City, CA). Fluorogenic
probe for control GAPDH gene was labeled with the VIC
reporter dye. Probes for both target genes CRP and IL-1βMediators of Inﬂammation 5
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Figure 3: Plasma leptin (a), adiponectin (b), visfatin (c) and (d) ghrelin levels in healthy control (CN, SHF, FR) and arthritic rats (AA-N,
AA-SHF, AA-FR) on day 18 after cFA inoculation. Signiﬁcant diﬀerences between healthy controls on diﬀerent dietary regime: ×P<. 05,
×××P<. 001. Signiﬁcant diﬀerences between control rats and arthritic rats on the same dietary regime: ∗∗P<. 01, ∗∗∗P<. 001. Signiﬁcant
diﬀerences between dietary modulated arthritic groups: #P<. 05, ##P<. 01 (AA-FR versus AA-N); ++P<. 01 (AA-FR versus AA-SHF). For
abbreviations see Figure 1.
were labeled with the FAM reporter dye. The reactions
contained TaqMan Universal Master Mix (Applied Biosys-
tems, Foster City, CA). Samples were run in triplicates.
The thermal cycling proceeded according to manufacturer’s
protocol: 40 cycles of 95
◦C for 15s and 60
◦Cf o r1m i nw i t h
one initial setup step 10min 95
◦C. Data were collected using
CFX96 Real-time system (Bio-Rad, Hercules, CA). Input
RNA amounts were calculated with a multiple comparative
method for the mRNAs of interest and GAPDH. Statistical
analysis was performed using Genex Ver. 5 software (MultiD
Analyses AB, Goteborg, Sweden).
2.7. RNA Preparation and Quantitative TaqMan PCR Proce-
dure in the ARC. Poly(A)RNA was isolated from the ARC
using Chemagic mRNA Direct Kit (Chemagen Biopolymer-
Technologie, Beasweiler, Germany). The signal was reversely
transcribedtocDNAbyareactioncontainingOmniscriptRT
Kit (Qiagen, Valencia, CA) components (RT buﬀer, RNase
free water, dNTP mix, Omniscript Reverse Transcriptase),
RNase inhibitor (Takara, Shiga, Japan), and pd(N)6 random
hexamer primers (Amersham Biosciences, Piscataway, NJ).
The expressions of NPY, AgRP, POMC, CART, and IL-1β
were quantiﬁed using ABI Prism 7000 Sequence Detector6 Mediators of Inﬂammation
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Figure 4:Anorexigenic(a)andorexigenic(c)neuropeptideandIL-
1β ( b )m R N Ae x p r e s s i o n si nt h eA R Ci nh e a l t h yc o n t r o l( C N ,S H F ,
FR) and arthritic rats (AA-N, AA-SHF, AA-FR) on day 18 after cFA
inoculation. Results are expressed in arbitrary units as the ratio of
given mRNA to 18S rRNA. Signiﬁcant diﬀerences between healthy
controls on diﬀerent dietary regime: ×P<. 05, ××P<. 01, ×××P<
.001. Signiﬁcant diﬀerences between control rats and arthritic rats
on the same dietary regime: ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001.
Signiﬁcant diﬀerences between arthritic groups: ##P<. 01, ###P<
.001 (AA-FR versus AA-N); ++P<. 01, +++P<. 001 (AA-FR versus
AA-SHF); ††P<. 01, †††P<. 001 (AA-SHF versus AA-N). For
abbreviations see Figure 1.
and System Software (Applied Biosystems, Foster City, CA).
The reactions were performed with TaqMan gene expression
products (Applied Biosystems, Foster City, CA) as detailed in
our previous study [19].
2.8. Statistical Analysis. For the statistical analysis it was
used Welch version of two-sample t-test with unequal
variances. Bonferroni correction was applied to treat the
multiplecomparisons.AdjustedP value<. 05wasconsidered
statistically signiﬁcant. Data are presented as means ± SEM
for each group.
3. Results
3.1. Body Mass, Food Intake, and Arthrogram Score. Chronic
inﬂammatory arthritis was associated with severe weight loss
inallgroups.Itstarted10daysaftercFAinjectioninnormally
fed arthritic rats and continued throughout the experiment.
However,weightlossoffood-restrictedarthriticandarthritic
rats on high-fat diet was not visible until the day 4 of AA.
In spite of the fact that control rats on high-fat diet gained
weight in considerably higher rate than normally fed control
rats from the 9th week of life onwards, arthritic rats on both
diets had similar body mass during the whole course of the
disease. However, we observed signiﬁcantly higher amounts
of mesenteric fat (AA-SHF 358.00 ± 67.4mg versus AA-N
174.29 ± 32.7mg, P <.001) and epididymal fat (AA-SHF
542.88 ± 58.3mg versus AA-N 360.13 ± 18.3mg, P<.001)
in AA rats on high-fat diet than in normally fed AA rats. As
expected, control and arthritic food-restricted rats displayed
decreased body mass values from day 4 to 18 after the
injection of cFA (Figure 1(a)).
In the arthritic groups as well as in the control groups,
the values of calorie intake per cage reﬂected the values of
body mass (Figure 1(b)). The clinical signs such as redness,
and swelling of paws appeared from day 12 of AA onwards
in all arthritic groups. Signiﬁcant reduction in arthrogram
score was observed in food-restricted arthritic rats, and
conversely,arthriticratsonhigh-fatdiethadincreasedvalues
of arthrogram score compared to the other arthritic groups
(Figure 1(c)).
3.2. Corticosterone, CRP, and IL-1β. Plasma corticosterone
levels were aﬀected by arthritis as well as by the dietary
interventions. All arthritic groups had signiﬁcantly elevated
corticosterone compared to their respective controls, more-
over corticosterone level of food-restricted arthritic rats was
signiﬁcantly more pronounced than in the other arthritic
rats. There were also signiﬁcant changes in corticosterone
levels among the control groups, showing mild increase
in control rats on high-fat diet compared to control rats
on normal diet, and a very pronounced increase in food-
restricted rats compared to normally fed and high-fat diet
fed rats (Figure 2(a)). The levels of plasma CRP as well as
the mRNA expressions of CRP in the liver were signiﬁcantly
elevated in normally fed and high-fat diet fed arthritic rats
compared to their respective controls. The activation of
plasma CRP in the arthritic rats on food-restriction wasMediators of Inﬂammation 7
signiﬁcantly less pronounced than in the other arthritic
groups, and moreover, its hepatic mRNA expression was not
enhanced at all. In the control rats food restriction reduced
plasma CRP levels compared to the other 2 control groups,
and a slight but signiﬁcant decrease of CRP plasma levels
occurred also in control rats on high-fat diet compared to
normally fed control rats (Figures 2(b) and 2(d)). Chronic
inﬂammatory arthritis caused clear-cut increase in IL-1β
mRNAexpressionintheliverinalldietarymodulatedgroups
with several times higher values in arthritic rats on high-fat
diet over the normally fed or foodrestricted arthritic rats.
Similarly, control rats on high-fat diet displayed increased
IL-1β mRNA expression in the liver relative to normally
fed or food-restricted control rats (Figure 2(c)). The IL-1β
expression represents a pool originating from liver cells and
also from circulating white blood cells accumulated in the
liver, since we used native liver without perfusion.
3.3. Adipokines and Ghrelin. Plasma leptin and adiponectin
levels were signiﬁcantly decreased in all arthritic groups
comparing to their corresponding controls. Overfeeding
resulted in the increase of leptin and decrease of adiponectin
levels compared to normofeeding or food restriction only in
control, but not in arthritic rats (Figures 3(a) and 3(b)). In
addition, food restriction during arthritis resulted in signif-
icantly lower levels of leptin compared to the other dietary
modulated arthritic rats (Figure 3(a)). Plasma visfatin levels
increased equally in all arthritic groups of rats comparing
to their respective controls. There were no diﬀerences in
visfatin values with respect to the dietary interventions in
arthritic rats (Figure 3(c)). All groups of arthritic rats had
higher plasma ghrelin levels than their corresponding con-
trols. The food-restricted arthritic rats showed signiﬁcantly
enhanced ghrelin levels compared to the other arthritic rats
(Figure 3(d)).
3.4. Neuropeptide and IL-1β mRNA Expressions in the ARC.
The mRNA expressions of the anorexigenic POMC in
the ARC did not diﬀer between arthritic rats and their
corresponding controls. However, the mRNA expressions
of the anorexigenic CART were signiﬁcantly lower in all
arthritic rats comparing to their controls. It is important to
notethatfoodrestrictionresultedindecreasedvaluesofboth
POMC and CART mRNA expressions compared to the other
dietary regimes with or without arthritis. Overfeeding in
arthriticratsincreasedmRNAexpressionofCARTcompared
to normofeeding in arthritic rats (Figure 4(a)). The mRNA
expression of IL-1β in the ARC was signiﬁcantly increased by
chronic inﬂammatory arthritis in all dietary modulated rats.
Food restriction led to the lower IL-1β mRNA expressions
in both arthritic and control rats than in the other dietary
modulatedarthriticandcontrolrats.Incontrast,overfeeding
led to the enhanced IL-1β mRNA expression compared
to normofeeding only in controls (Figure 4(b)). Evaluation
of the mRNA expression for the orexigenic NPY in the
ARC showed its upregulation during arthritis. Moreover,
in control groups both food restriction and overfeeding
caused increased NPY mRNA in the ARC compared to
normofeeding. Therefore, no signiﬁcant diﬀerences could
be revealed between control and arthritic rats on high-
fat diet, or between food-restricted control and arthritic
rats. However, both food-restricted and high-fat diet fed
arthritic rats showed enhanced NPY mRNA expressions over
normally fed arthritic rats, and food-restricted arthritic rats
showed enhanced NPY mRNA compared to arthritic rats
onhigh-fatdiet.Chronicinﬂammatoryarthritissigniﬁcantly
enhanced mRNA expression for another orexigenic peptide,
AgRP in all dietary modulated groups. This eﬀect was more
pronounced in food-restricted arthritic rats compared to
normally fed arthritic rats. Similarly as NPY mRNA, AgRP
mRNA expression was increased in both food-restricted and
high-fat diet fed control groups. Plus, the values of AgRP
mRNA in food restricted controls were more pronounced
than those in controls on high-fat diet (Figure 4(c)).
3.5. Parameters of Metabolism. Food restriction during
arthritis led to a reduction of basal glucose, and insulin
plasma levels, and consequently to a reduction of HOMA
index compared to food restriction in controls or to the
other dietary regimes during arthritis (Figures 5(a), 5(b),
and 5(c)). Overfeeding resulted in enhanced triglyceride
and cholesterol concentrations in the liver of arthritic rats
compared to those on the other dietary regimes (Figures
5(d) and 5(e)). In addition, control rats on high-fat diet
had also higher triglyceride concentrations than control
food-restricted rats (Figure 5(d)). Interestingly, arthritis in
all dietary regimes led to the increased cholesterol levels
(Figure 5(e)).
4. Discussion
This study shows that feeding status modulates the disease
severity, mRNA levels of IL-1β and of the key neuropeptides
regulatingappetiteintheARC,aswellasmetabolicresponses
in chronic adjuvant arthritis.
4.1. Feeding Status and AA Severity. Our study conﬁrmed
previous observations that AA under the condition of
normofeeding decreased circulating levels of leptin [18, 22,
23], and adiponectin [19, 23, 24], and increased circulating
levels of visfatin [25], ghrelin [19, 26], and corticosterone
[7, 18, 19, 27]. Regarding the severity of arthritis, the most
important ﬁnding of this investigation is the reduced arthro-
gramscoreassociatedwithaprofounddecreaseofcirculating
leptin and a marked increase of circulating ghrelin and
corticosterone levels due to the food restriction. This ﬁnding
is in a good agreement with the known immunomodulatory
functions of the respective hormones. Downregulation of
leptin or its deﬁciency has been shown to prevent Th1-
mediated autoimmune diseases such as RA [6], autoimmune
arthritis [8], and encephalomyelitis in mice [28]. Admin-
istration of ghrelin or ghrelin agonists stimulated antiin-
ﬂammatory responses in various autoimmune inﬂammatory
diseases including AA in rats [22, 29–31]. Glucocorticoids
are known to regulate Th1/Th2 lymphocyte balance towards
Th2 pattern by suppressing Th1 cytokine production [32].8 Mediators of Inﬂammation
Consistently with the improvement of arthrogram score in
food-restricted arthritic rats, we observed an attenuation of
inﬂammatory parameters such as a decrease of CRP plasma
levels, and of CRP and IL-1β mRNA expressions in the liver.
This suggests that the food restriction-induced inhibition of
leptin, activation of ghrelin, and corticosterone contributed
to the attenuation of the disease.
In this study, overfeeding led to a worsened arthrogram
score along with stronger inﬂammatory response manifested
by a higher IL-1β mRNA expression in the liver. However,
plasmaleptinandadiponectinlevelsinarthriticratsonhigh-
fat diet were similar to those found in normally fed arthritic
rats, despite the fact that rats on high-fat diet had high leptin
levels and low adiponectin levels before AA induction as we
reported recently [17].Productionandsecretionofleptinare
primarily dependent on the amount of body fat mass [33].
Even though we observed a higher amount of mesenteric
and epididymal fat in arthritic rats on high-fat diet than in
normally fed arthritic rats, its secretion was less eﬀective due
to the inﬂammatory process.
Under physiological conditions weight loss increases
adiponectin levels [34, 35], and decreases visfatin levels
[35, 36], but in inﬂammatory arthritis there were opposite
results[19,23–25,37].Ourstudyhasshowndownregulation
of adiponectin and upregulation of visfatin levels during
AA to the same extent in all feeding regimes. Based on
previouslypublished reports [34,38–42],theincreasedlevels
of corticosterone and proinﬂammatory cytokines may be
involved in this regulation in arthritic rats. The worsening of
arthritis in rats on high-fat diet is diﬃcult to explain on the
basis of the present results. The pathophysiology of obesity
is very complex, and various pro-inﬂammatory factors can
negatively contribute to the disease outcome. One of these
factors could be the overfeeding-induced hyperleptinemia
[17] which presumably took eﬀect at the onset of AA, but
not in the further progress of the disease.
4.2. AA Cachexia and mRNA Expressions in the ARC under
DiﬀerentFeedingConditions. Wehaverecentlydemonstrated
an enhanced mRNA expression of IL-1β in the ARC of nor-
mallyfedarthritic ratssuggestingits rolein arthritis-induced
cachexia [19]. This study clearly shows that AA led to an
up-regulation of IL-1β mRNA in the ARC, and moreover to
reduced CART, unchanged POMC and increased NPY and
AgRP mRNA expressions under all dietary interventions. In
addition, food-restriction led to a more profound decrease
of mRNA expressions for anorexigenic factors (POMC,
CART, IL-1β) and marked increase of mRNA expressions
for orexigenic factors (NPY, AgRP) compared to the other
dietary regimes with or without arthritis.
T h ei m p o r t a n c eo fI L - 1 β in the development of inﬂam-
matory cachexia was previously reported in experimental
models of chronic inﬂammatory diseases, such as cancer
or colitis, in which neutralization of IL-1β attenuated
inﬂammatory anorexia [43, 44]. As for nutritional status,
acute inﬂammation-associated anorexia in rats was reduced
by prior food-restriction [45, 46]. Moreover, the sensitivity
to IL-1β-induced anorexia was decreased in food-restricted
rats [47, 48]. Therefore, we may hypothesize that down-
regulation of IL-1β mRNA in the ARC observed in our
study due to the food restriction may have contributed to
the reduced cachectic response in chronic arthritis. It is
diﬃcult to assess a direct relationship between central IL-
1β expression and inﬂammatory cachexia since we did not
perfuse the rats in this study. However, regardless whether
IL-1β mRNA expression in the ARC is of central origin, it
may alter the secretion and function of key neuropeptides
regulating energy balance. Noteworthy, previous studies
demonstrated that IL-1β induced Fos immunoreactivity in
both POMC and NPY-expressing neurons in the ARC [49]
and c-fos mRNA expression in AgRP neurons in the ARC
[50].
Similarlytoourﬁndings,indiﬀerentmodelsofacuteand
chronic inﬂammation-induced anorexia, increased mRNA
expression of NPY and AgRP has been observed in the
hypothalamus or ARC [50–54]. In the present study, mRNA
levels of AgRP and NPY in the ARC were aﬀected by
both the energy status and the inﬂammation. Regarding
the energy status, AgRP and NPY mRNAs were increased
by food restriction as well as by overfeeding in healthy
rats. One possible mechanism could lie in increased levels
of corticosterone, a highly active stimulator of NPY/AgRP
mRNA expressions [55]. Additionally, this ﬁnding reﬂects
normal physiological response to fasting in food-restricted
control rats [56, 57], but leptin resistance in control rats
on high-fat diet as we described previously using the same
feeding protocol [17]. As for the inﬂammation, AA was asso-
ciated with low circulating leptin levels along with increased
circulating ghrelin as well as corticosterone levels. These
hormonal changes normally increase NPY/AgRP mRNA
expression in the hypothalamus [55, 58, 59]. Therefore the
upregulation of NPY/AgRP mRNA expression in the ARC
is not surprising in arthritic rats, and reﬂects physiological
response in cachexia. However, there is a discrepancy why
upregulated expressions of orexigenic neuropeptides did
not increase appetite in AA. It appears that inﬂammatory
signaling in the hypothalamus has counteracted orexigenic
response of NPY/AgRP neurons. This could involve negative
interference with protein synthesis or release of neuropep-
tides, as demonstrated by Scarlett et al. [50].
POMC, a precursor of the anorexigenic α-melanocyte-
stimulating hormone, and CART are colocalized in the same
ARC neurons, and their mRNA expressions are stimulated
by increased leptin signaling [12]. Consistently with low-
leptin levels in AA, we found a decreased mRNA expression
of CART in the ARC. This is in line with previous ﬁndings
observed in cachectic tumor-bearing rats [53]. However,
mRNA expression of POMC in the ARC did not diﬀer
signiﬁcantly from controls in arthritic rats under all feeding
conditions. Likewise, neither cachectic tumor-bearing rats
[60, 61], nor LPS-treated rats [62] did demonstrate changes
in hypothalamic or ARC mRNA expression of POMC. It
thus appears that the anorexigenic contribution of the ARC
POMC/CART mRNAs was less important during AA.
Our results suggest that modulation of mRNA levels for
the key hypothalamic neuropeptides regulating appetite is
not the primary mechanism by which AA induces cachexia.Mediators of Inﬂammation 9
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Figure 5: Basal plasma levels of glucose (a) and insulin (b), HOMA index (c), and liver concentrations of triglycerides (d) and cholesterol
(e) in healthy controls (CN, SHF, FR) and arthritic rats (AA-N, AA-SHF, AA-FR) on day 18 after cFA inoculation. Results are expressed as
means ± SEM. Signiﬁcant diﬀerence between healthy controls on diﬀerent dietary regime: ×P<. 05. Signiﬁcant diﬀerences between control
rats and arthritic rats on the same dietary regime: ∗P<. 05, ∗∗P<. 01, ∗∗∗P<. 001. Other statistical diﬀerences: AA-FR versus AA-N
#P<. 05, ###P<. 001; AA-FR versus AA-SHF +P<. 05, ++P<. 01; AA-SHF versus AA-N ††P<. 01. For abbreviations see Figure 1.
On the other hand, increased IL-1β mRNA in the ARC in
the present study highlights the importance of this pro-
inﬂammatory cytokine among mechanisms through which
chronic inﬂammation aﬀects energy homeostasis.
4.3. AA and Metabolic Response under Diﬀerent Feeding
Conditions. Chronic systemic inﬂammation in RA is impli-
cated in the development of insulin resistance [63]. Further-
more, in inﬂammatory arthritis, overweight considerably
contributes to insulin resistance, while calorie restriction
together with disease-modifying antirheumatic drugs result
in its improvement [64]. Our previous results showed
downregulation of glucose transporter GLUT4 in adipocyte
membranes in arthritic rats that may indicate decreased
insulin sensitivity in AA [25]. In this study we did not
observeanysigniﬁcantchangesinHOMAindex,innormally
fed or arthritic rats on high-fat diet. Interestingly, arthritic
rats on food restriction showed higher insulin sensitivity
documented by a decreased HOMA index. Both adiponectin
and visfatin are suggested to increase insulin sensitivity [10,
15], but regarding the similar plasma levels of adiponectin
and visfatin in all arthritic groups, there cannot be assessed
any link between these adipokines and improved insulin sen-
sitivity in food-restricted arthritic rats. However, these rats
showed markedly increased plasma ghrelin and suppressed
plasma leptin levels compared to the other arthritic rats.
Ghrelin has been found to stimulate insulin-induced glucose
uptake in adipocytes [65]; and coadministration of acylated
and unacylated ghrelin strongly improved insulin sensitivity
inhumans[66].Itthusappearsthatelevatedghrelincouldbe
functionally associated with improved insulin sensitivity in
food-restricted arthritic rats. On the other hand, a decrease
of leptin levels associated with the reduction of body mass
has been implicated in the pathogenesis of insulin-deﬁcient10 Mediators of Inﬂammation
diabetes, in which leptin replacement improved insulin
sensitivity and decreased hepatic triglyceride content [67].
Moreover, leptin is proposed as an important antisteatotic
hormone protecting nonadipose tissue from fat accumula-
tion and lipotoxicity [68]. Here we found unchanged hepatic
triglyceride concentration in food-restricted arthritic rats.
However, hepatic cholesterol concentrations were increased
in food-restricted arthritic rats compared to their healthy
controls but not to normally fed arthritic rats. Thus, we
cannot exclude that leptin downregulation may have detri-
mental consequences on lipid metabolism during chronic
inﬂammation.
Our results further show increased hepatic triglyceride
and cholesterol levels in arthritic rats on high-fat diet
compared to the arthritic rats on the other diets, despite
normal values of HOMA index. An increased triglyceride
deposition in the liver could be due to the excessive
inﬂux of free fatty acids from high-fat diet consumption
a si tw a sp r e v i o u s l yo b s e r v e di nr a t s[ 69] and humans
[70]. In our study high-fat diet contained 45% calories as
fat, predominantly as lard containing 39% saturated fat.
Recent ﬁndings have shown a causal relationship between
activation of inﬂammatory process and the concentrations
of saturated free fatty acids in the diet [71]. Noteworthy,
we observed increased IL-1β expression in the liver in
arthritic rats on high-fat diet. Since IL-1β is at least partially
involved in the development of hepatic steatosis [72], it
may also play a considerable role in maintaining increased
hepatictriglycerideconcentrationinarthriticratsonhigh-fat
diet.
5. Conclusions
5.1. Arthritis Severity. In food restriction, the attenuation of
chronic arthritis seems to be related to the downregulation
of leptin and upregulation of ghrelin and corticosterone. In
rats on high-fat diet the aggravation of AA is not related
to the modulation of these hormones. However, initial
hyperleptinemia at the time of the disease onset could
have accelerated its progression. Circulating visfatin and
adiponectin levels do not reﬂect the disease severity.
5.2. Control of Appetite. Overexpression of IL-1β in the
ARC of arthritic rats on all dietary regimes indicates its
role in AA- induced cachexia rather than anorexigenic neu-
ropeptides CART and POMC. Overexpressions of orexigenic
NPY and AgRP and lowered expressions of anorexigenic
CART in the ARC suggest low eﬀectivity of these compen-
satory mechanisms against negative energy balance during
AA.
5.3. Metabolism. HOMA index in arthritic rats on high-fat
diet, normal diet, and food-restriction does not indicate the
developmentofinsulinresistance.Elevatedconcentrationsof
total cholesterol and triglycerides in the liver of arthritic rats
on high-fat diet indicate impaired lipid metabolism due to
the increased inﬂammation in these rats.
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